Picture of Hong Kong Pharma Digital Technology Holdings logo

HKPD Hong Kong Pharma Digital Technology Holdings Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapValue Trap

Annual cashflow statement for Hong Kong Pharma Digital Technology Holdings, fiscal year end - March 31st, USD millions except per share, conversion factor applied.

2023
March 31st
2024
March 31st
2025
March 31st
Period Length:12 M12 M12 M
Source:PROSPECTUSPROSPECTUS20-F
Standards:
IFRS
IFRS
IFRS
Status:FinalFinalFinal
Net Income/Starting Line0.9981.33-0.027
Depreciation
Non-Cash Items0-0.0010.043
Unusual Items
Other Non-Cash Items
Changes in Working Capital0.014-2.65-0.52
Change in Accounts Receivable
Change in Inventories
Change in Accounts Payable
Change in Taxes Payable
Change in Other Liabilities
Cash from Operating Activities1.73-0.3940.569
Capital Expenditures-0.118-0.088-0.155
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items-0.0140.047-2.3
Sale of Fixed Assets
Change in Net Investments
Other Investing Cash Flow
Cash from Investing Activities-0.132-0.041-2.45
Financing Cash Flow Items00.1642.92
Other Financing Cash Flow
Net Issuance / Retirement of Debt
Cash from Financing Activities-1.160.5372
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash0.440.1030.122